http://stoneleaflamps.com/classic-looks-with-tiffani-style-lamps.html
Hematide is in a Phase III trial. Rentomn led Onyx for nearly 15 years, stepping down in February 2008as CEO, chairman and a member of Onyx’es board. At the company, he helped negotiate a research, development and commercializatiohn partnership with that resulted inthe anti-cancer drug Nexavar tablets, which cost about $5,000 a month in the Uniteed States and are approaching $1 billion in annual are approved in more than 80 countries to treayt kidney cancer and 70-plus countries for liver Prior to joining Onyx, Rentojn was president and COO of Chiron, which acquiref Cetus in 1991. Renton had been president of Cetuzsince 1990, COO since 1987 and CFO from 1983 to 1987.
Rentoj also serves on the boardsof , Cepheifd and the Special Olympics of Northern
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment